Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment

por Rosewell Shaw, Amanda, Suzuki, Masataka
Publicado 2018

Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives

por McKenna, Mary K., Rosewell-Shaw, Amanda, Suzuki, Masataka
Publicado 2020

HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy

por Rosewell Shaw, Amanda, Porter, Caroline, Biegert, Greyson, Jatta, Lisa, Suzuki, Masataka
Publicado 2022

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

por Rosewell Shaw, Amanda, Porter, Caroline E., Yip, Tiffany, Mah, Way-Champ, McKenna, Mary K., Dysthe, Matthew, Jung, Youngrock, Parihar, Robin, Brenner, Malcolm K., Suzuki, Masataka
Publicado 2021

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

por Wang, Daniel, Porter, Caroline E., Lim, Bora, Rosewell Shaw, Amanda, Robertson, Catherine S., Woods, Mae L., Xu, Ya, Biegert, Greyson G.W., Morita, Daisuke, Wang, Tao, Grilley, Bambi J., Heslop, Helen, Brenner, Malcolm K., Suzuki, Masataka
Publicado 2023